AbCellera Biologics Inc. v. Bruker Cellular Analysis, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 ABCELLERA BIOLOGICS INC, et al., Case No. 20-cv-08624-JST (VKD)
Plaintiffs,
ORDER RE MARCH 14, 2025
v. DISCOVERY DISPUTE RE NIH AND
NIAID AGREEMENTS
BRUKER CELLULAR ANALYSIS, Re: Dkt. Nos. 321, 322 Defendant.
12 Further to the Court’s order at Dkt. No. 309, the Court has reviewed and considered the parties’ additional arguments regarding defendant Bruker Cellular Analysis, Inc.’s (“Bruker Cellular”) demand for complete, unredacted copies of the following documents: 1. May 4, 2020 Patent License Agreement between plaintiff AbCellera Biologics, Inc. (“AbCellera”) and the National Institute of Allergy and Infectious Diseases (“NIAID”) (“2020 NIH/NIAID Agreement”); 2. Other agreements listed in Section 1 of the 2020 NIH/NIAID Agreement; 3. AbCellera’s “royalty reports” to the NIH under the 2020 NIH/NIAID Agreement; and 4. March 12, 2019 Research Collaboration Agreement between AbCellera,…